Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.
Business Wire
BAD HOMBURG, Germany--(BUSINESS WIRE)-- #FreseniusKabi--Fresenius, via its operating company Fresenius Kabi, announced today the..